G protein-coupled receptors in major psychiatric disorders.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortexMembrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors.Metabolic parameters and emotionality are little affected in G-protein coupled receptor 12 (Gpr12) mutant miceNCAM180 regulates Ric8A membrane localization and potentiates β-adrenergic responseGNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognitionAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionVirtual screening of GPCRs: an in silico chemogenomics approach.Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholismSelective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screeningAnti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells.The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent mannerGenetic associations of brain structural networks in schizophrenia: a preliminary studyEvidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.GRK5 promotes F-actin bundling and targets bundles to membrane structures to control neuronal morphogenesisG protein-coupled receptor kinases: more than just kinases and not only for GPCRsThe C825T Polymorphism of the G-Protein β3 Gene as a Risk Factor for Depression: A Meta-Analysis.Calcium-independent inhibitory G-protein signaling induces persistent presynaptic muting of hippocampal synapses.Intracellular Loop 2 Peptides of the Human 5HT1a Receptor are Differential Activators of Gi.Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonistsDecreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action.Genetic Variations in the Serotonergic System Mediate a Combined, Weakened Response to SSRI Treatment: A Proposed Model(1,2)The complex of G protein regulator RGS9-2 and Gβ(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatumChildhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.Neurobiology of bipolar disorder.Overexpression of diacylglycerol kinase η enhances Gαq-coupled G protein-coupled receptor signaling.Psychiatric neural networks and neuropharmacology: Selected advances and novel implicationsMinireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes.Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.GPCR assay automation for leveraging lead optimization.Predicting new indications of compounds with a network pharmacology approach: Liuwei Dihuang Wan as a case study.Deficiency of diacylglycerol kinase η induces lithium-sensitive mania-like behavior.Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia.Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.Multiplexed profiling of GPCR activities by combining split TEV assays and EXT-based barcoded readouts.
P2860
Q24645703-4DA7C5F9-EB0D-4AB2-AF4B-D0156649F047Q24655753-B22C1F33-0F85-4663-9A22-6B719E9217BFQ27300848-BAB081FD-10C1-4A88-BE2A-7111E8989B29Q28482102-BC8C7F84-4815-4404-A5CA-8CB4B5568E51Q28731849-05A3F7F5-C24F-49FB-BAFF-D3C491D56707Q28975772-A71F615C-05BB-44CD-8FD1-7F26E2C7473BQ30386608-E62478B9-7DF5-4078-BE7C-C6F435EA374FQ33367388-9F04BBD5-ECAB-4F43-B515-EECAB5C7777BQ33548809-81C701EA-0056-45E9-94C1-410DE9B3BE73Q33574694-3863AACD-6B68-43CE-961A-A43C8BD9258EQ33632351-A5710E8B-9B68-4C56-AB23-9157960A33E5Q33927277-4F43E0FC-9295-4A38-A998-C257281562DCQ34343604-94489F96-E24D-4B8B-878E-F18CB56DBE67Q34654354-3F9CB863-E308-4F85-A81C-634951DCF691Q35514293-D1F02B22-5C83-4886-880D-18FD3576D4C3Q35621624-602B8587-433B-4E50-8715-817FA8C502ECQ35683649-D7202B4A-E323-4FA1-9A4F-7E4E7088B4CEQ35851372-E7B0CBDE-C378-44B8-AA1C-259E7D55D13DQ35977592-001C581A-A47F-4AD6-AC2A-E181F830F683Q35996463-D407FD2A-59CE-4B27-BCA7-35CC0E3425B6Q36037385-2431B059-FA44-4E57-9B5F-A63FC6FD567AQ36103263-5DE8EF82-85B4-4D6D-84B0-735B040D177DQ36634572-C42F7E88-61DC-4CF8-9ED6-DA8F7A6CB9F1Q36896730-A445F27C-7C73-48B3-B980-DB6FE7526B50Q36949575-3CBF9DB5-BE90-4769-B624-D036C1AC8E3FQ37035241-FAF757C5-64E8-47CC-AF3F-A292178826C6Q37708120-3AECCBE8-8D93-4792-BAB6-306DF3B6E488Q38197608-5F7F2E00-3BE1-4AAC-A1DA-E4FEAEDF6365Q38459674-9861972A-E382-4AF9-BCA4-0EE5A66F3734Q38661128-962F2FC1-5315-4FB9-B7FF-95DC5BB16A7CQ38716504-D64B454A-1630-4686-91CD-B79AE4E3B69AQ39609464-DF13DB2D-A3AA-495F-9292-73F5FA337C2CQ39997649-384ADA2B-02E4-4AC3-BD95-A7A9870839C2Q43509575-B52DCC28-F8D6-4744-9888-6FA3CA537D6FQ43528588-C24469A7-CBB8-47BE-A756-432D1F6D3C56Q47099004-204B2A6C-B709-455A-AEE1-687A25BBADCDQ47431792-82EA9902-08F8-4DF9-A61E-EBA919CD6F13Q47602743-EB765852-D6D4-4050-AF8E-D76106E8EF25Q48196436-2C240764-5E72-4A0A-89D5-FE45828FAFE3Q55129313-C35BBBF1-0322-41C3-943C-8B6047F63319
P2860
G protein-coupled receptors in major psychiatric disorders.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
G protein-coupled receptors in major psychiatric disorders.
@ast
G protein-coupled receptors in major psychiatric disorders.
@en
G protein-coupled receptors in major psychiatric disorders.
@nl
type
label
G protein-coupled receptors in major psychiatric disorders.
@ast
G protein-coupled receptors in major psychiatric disorders.
@en
G protein-coupled receptors in major psychiatric disorders.
@nl
prefLabel
G protein-coupled receptors in major psychiatric disorders.
@ast
G protein-coupled receptors in major psychiatric disorders.
@en
G protein-coupled receptors in major psychiatric disorders.
@nl
P2860
P1476
G protein-coupled receptors in major psychiatric disorders.
@en
P2093
Husseini K Manji
Lisa A Catapano
P2860
P304
P356
10.1016/J.BBAMEM.2006.09.025
P407
P577
2006-10-03T00:00:00Z